EGFR and glioblastoma: In GBM, the most common oncogenic mutation of EGFR, termed EGFRvIII, is characterized by the deletion of exons 2 to 7, resulting in an in-frame loss of 267 amino acids in the extracellular domain of the EGFR protein [29].